AusPAR: Keytruda

Australian Public Assessment Report

AusPAR

AusPAR: Keytruda [PDF, 1.82 MB]

AusPAR: Keytruda [Word, 3.54 MB]

Attachment-Product information for Keytruda [PDF, 2.14 MB]

Attachment-Product information for Keytruda [Word, 2.7 MB]

Device/Product Name

Keytruda

Active ingredients

Pembrolizumab

AusPAR Date

30 August 2023

Published

4 September 2023

Submission Number

PM-2021-04316-1-4

Submission Type

Extension of indications

Decision

Approved